European post-marketing observational prospective cohort study of children with type I diabetes treated with Apidra.

Trial Profile

European post-marketing observational prospective cohort study of children with type I diabetes treated with Apidra.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2016

At a glance

  • Drugs Insulin glulisine (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 06 May 2012 Additional lead trial investigator (Dr Stephen Greene) identified ans additional locations (England, Scotland) identified as reported by United Kingdom Clinical Research Network record.
    • 06 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
    • 23 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top